The period prevalence of Huntington's disease (HD) in Hong Kong Chinese was 3-7 per million population. HD patients in Mainland China and Hong Kong showed similar hereditary pattern, clinical and pathological features as in the West. Chinese HD patients were male predominant with a younger age of onset and death. Their ancestral origin could be traced mostly to the coastal provinces of China. It is proposed that Chinese HD patients may have a European origin and share the same gene pool as their white counterparts. (7 Neurol Neurosurg Psychiatry 1992;55:681-684) 
Accepted 25 November 1991 The prevalence of HD in the West varies from 40-100 per million population with pockets of high density in some areas. ' The origin of most cases in white populations can be traced to their ancestors who left England, France or the Netherlands in the 17th or 19th century. 26 The European origin of the HD in Australia, North and South America is undisputed. 7 Literature on HD in the East is limited due to the relative rarity of the disease. In Japan, the first case was reported in 1935 by Kishimoto. The prevalence was 4/106 in the Aichi province, approximately one-tenth that of the Western countries. 8 The negative assortive marriage, incomplete penetrance (penetrance estimated to be 0-94) and above all low detection rate were reasons cited as an explanation of the low prevalence rate. More recent data suggested an even lower figure of 1 1/106 in the Ibaraki Prefecture. 9 The annual death rate from HD in Japan was estimated to be 0 15 per million population, again about onetenth of the figure in the West. ' provinces respectively (figure). Most of them clustered at the coastal provinces of Jiangsu (35%), Hebei (16%) and Guangdong (13%). Two inland provinces, Henan and Anfei, which also reported a fair number of cases, are located just adjacent to Jiangsu and Hebei. The location of reporting centres more or less overlapped with the origin of patients reported (figure), but one family reported from Xinjiang near the western border of China were originally from Jiangsu.
Discussion
The lack of systematic survey of HD in Mainland China precludes precise estimation of its prevalence. This study in Hong Kong Chinese shows that the period prevalence (1984-91) of the disease was 3-7 per 106 and the point prevalence at 1991 was 2-5 per 106, figures that approximate that reported in Japan.9 Since our study is not a door-to-door population survey, our prevalence data are probably a reasonable though not a full estimate.
The mode of inheritance was invariably autosomal dominant although positive family history could not be obtained in 19%. Since new mutation is rare (less than 0-1%) and penetrance high in HD,32 the lack of positive family history could best be explained by illegitimacy, denial of the illness, or the chorea in the parents was mild and escaped detection. Internal migration due to war and natural disasters certainly made case-tracing more difficult. An interesting feature in Chinese HD patients, which differs from western findings, was the male predominance both in sex distribution and disease transmission. Paternal transmission was found in two thirds of our patients who had positive history. One possible explanation is sampling bias against the female sex who have a lower social status in the Chinese society, thus attracting less social and medical attention.
The mean age of onset (34-8 years) and age of death (43-0 years) were significantly younger, and the mean duration of illness (8-2 years) were shorter than figures in the West.4 [34] [35] [36] [37] Difference in defining the onset of illness, the standard of medical care and the variation of virulence in different ethnic groups are possible explanations. The favourable influence of maternal factors in the onset of HD3338 was not borne out in our current study, as HD patients with either paternal or maternal transmission showed no difference in the age of onset.
The concentration of cases in the coastal region of China, namely the Jiangsu and Hebei Provinces, is an interesting phenomenon. One explanation may be that these are the more prosperous areas with better medical service and thus a better chance of case discovery and reporting. However, other equally rich but non-coastal provinces, for example, Sichuan, have reported much fewer cases. Furthermore, the Jiangsu family reported in Xinjiang at the western border of China could be more than a coincidence.
This peculiar geographical distribution leads us to postulate that HD in Chinese is not indigenous but has a European origin. In Hong Kong3" and Taiwan,39 the oldest families that could be traced were five and four generations respectively. If 25 years is taken as one generation for procreation, the oldest case was probably born in the mid 1800s, when China was invaded by the West. The treaty ofNanking was signed in 1841 with the West gaining access to five ports, including Shanghai in Jiangsu Province,4" where the Chinese HD patients are concentrated. This date paralleled the arrival of the first HD patients at Tasmania andVenezuela. In contrast to countries like the United States and Venezuela, the disease in China has remained relatively localised in coastal regions. The "ultra-stable" infrastructure of the Chinese culture, hostility of the inland population towards Westerners, and young age of onset and death of Chinese HD patients would help limit extensive spread of the disease.
Racial admixture with white populations may explain the origin of HD in Japanese whose situation is analogous to the Chinese. They traded with the Dutch in the Edo era starting in mid 17th century and other Westerners since the Meiji era in the 19th century. In areas with more foreign contacts, for example, Aichi Province, there is a higher prevalence of HD than neighbouring areas.8 The Japanese HD gene has recently been found to be similar to its white counterparts in DNA marker studies.4' This preliminary analyss of Chinese HD patients provides primi facie evidence for our hypothesis. To substantiate it, further family tracing and genetic studies including human leucocyte antigen profiles and DNA analysis are required and currently in progress. Should the case be proven, further insight into this rare but tragic disease may be gained.
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